The effects of apigenin on the expression of Fas/FasL apoptotic pathway in warm liver ischemia-reperfusion injury in rats

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Tsalkidou, Evanthia G ^a   Tsaroucha, Alexandra K ^a   Chatzaki, Ekaterini ^a   Lambropoulou, Maria ^a   Papachristou, Fotini ^a   Trypsianis, Gregory ^a   Pitiakoudis, Michael ^a   Vaos, Georgios ^a   Simopoulos, Constantinos ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

APIGENIN; CASPASE 3; FAS ANTIGEN; FAS LIGAND; DIMETHYL SULFOXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTERY OCCLUSION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; HEPATIC ARTERY; LIVER ISCHEMIA; NICK END LABELING; NONHUMAN; PORTAL VEIN OBSTRUCTION; RANDOMIZATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; DRUG EFFECTS; ISCHEMIA; LIVER; METABOLISM; PATHOLOGY; REPERFUSION INJURY; SIGNAL TRANSDUCTION; WISTAR RAT;

ANIMALS; ANTIGENS, CD95; APIGENIN; APOPTOSIS; DIMETHYL SULFOXIDE; FAS LIGAND PROTEIN; LIVER; RATS, WISTAR; REPERFUSION INJURY; SIGNAL TRANSDUCTION; WARM ISCHEMIA;

EID: 84904636728     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/157216     Document Type: Article

References (25)

1. Teoh N. C., Farrell G. C., Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection. Journal of Gastroenterology and Hepatology 2003 18 8 891 902 10.1046/j.1440-1746.2003. 03056.x 2-s2.0-0042855206 (Pubitemid 37056167)
2. Jaeschke H., Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. The American Journal of Physiology-Gastrointestinal and Liver Physiology 2003 284 1 G15 G26 2-s2.0-0037229864 (Pubitemid 36076246)
3. Jaeschke H., Mechanisms of reperfusion injury after warm ischemia of the liver. Journal of Hepato-Biliary-Pancreatic Surgery 1998 5 4 402 408 2-s2.0-0032240594 (Pubitemid 128662611)
4. He S. Q., Zhang Y. H., Venugopal S. K., Dicus C. W., Perez R. V., Ramsamooj R., Nantz M. H., Zern M. A., Wu J., Delivery of antioxidative enzyme genes protects against ischemia/reperfusion-induced liver injury in mice. Liver Transplantation 2006 12 12 1869 1879 10.1002/lt.21001 2-s2.0-33845472283 (Pubitemid 44911814)
5. Devasagayam T. P. A., Tilak J. C., Boloor K. K., Sane K. S., Ghaskadbi S. S., Lele R. D., Free radicals and antioxidants in human health: current status and future prospects. Journal of Association of Physicians of India 2004 52 794 804 2-s2.0-19444387198 (Pubitemid 41279997)
6. Halliwell B., Antioxidants in human health and disease. Annual Review of Nutrition 1996 16 33 50 2-s2.0-0029824431 (Pubitemid 26286845)
7. Montalvo-Jave E. E., Escalante-Tattersfield T., Ortega-Salgado J. A., Piña E., Geller D. A., Factors in the Pathophysiology of the Liver Ischemia-Reperfusion Injury. Journal of Surgical Research 2008 147 1 153 159 10.1016/j.jss.2007.06.015 2-s2.0-43049136274 (Pubitemid 351626076)
8. Kerr J. F. R., Winterford C. M., Harmon B. V., Apoptosis: its significance in cancer and cancer therapy. Cancer 1994 73 8 2013 2026 10.1002/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO;2-J 2-s2.0-0028329172 (Pubitemid 24107952)
9. Malhi H., Guicciardi M. E., Gores G. J., Hepatocyte death: a clear and present danger. Physiological Reviews 2010 90 3 1165 1194 10.1152/physrev.00061. 2009 2-s2.0-77955591462
10. Gavrieli Y., Sherman Y., Ben-Sasson S. A., Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. Journal of Cell Biology 1992 119 3 493 501 10.1083/jcb.119.3.493 2-s2.0-0026648674
11. Takemura G., Kato S., Aoyama T., Characterization of ultrastructure and its relation with DNA fragmentation in Fas induced apoptosis of cultured cardiac myocytes. The Journal of Pathology 2001 193 546
12. Huerta S., Goulet E. J., Huerta-Yepez S., Livingston E. H., Screening and Detection of Apoptosis. Journal of Surgical Research 2007 139 1 143 156 10.1016/j.jss.2006.07.034 2-s2.0-33947591469 (Pubitemid 46482558)
13. Yin F., Giuliano A. E., van Herle A. J., Signal pathways involved in apigenin inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells (ARO). Anticancer Research 1999 19 5 B 4297 4303 2-s2.0-0032763752
14. Hirano T., Higa S., Arimitsu J., Naka T., Shima Y., Ohshima S., Fujimoto M., Yamadori T., Kawase I., Tanaka T., Flavonoids such as luteolin, fisetin and apigenin are inhibitors of interleukin-4 and interleukin-13 production by activated human basophils. International Archives of Allergy and Immunology 2004 134 2 135 140 10.1159/000078498 2-s2.0-2642580606 (Pubitemid 38716259)
15. Nakazawa T., Yasuda T., Ueda J., Ohsawa K., Antidepressant-like effects of apigenin and 2,4,5-trimethoxycinnamic acid from Perilla frutescens in the forced swimming test. Biological and Pharmaceutical Bulletin 2003 26 4 474 480 10.1248/bpb.26.474 2-s2.0-0442310605 (Pubitemid 39663592)
16. Safari M.-R., Sheikh N., Effects of flavonoids on the susceptibility of low-density lipoprotein to oxidative modification. Prostaglandins, Leukotrienes and Essential Fatty Acids 2003 69 1 73 77 10.1016/S0952-3278(03)00085-1 2-s2.0-0242409583 (Pubitemid 37421504)
17. Begum N., Prasad N. R., Thayalan K., Apigenin protects gamma-radiation induced oxidative stress, hematological changes and animal survival in whole body irradiated Swiss albino mice. International Journal of Nutrition, Pharmacology, Neurological Diseases 2012 2 45 52
18. Huguet C., Addario-Chieco P., Gavelli A., Arrigo E., Harb J., Clement R. R., Technique of hepatic vascular exclusion for extensive liver resection. The American Journal of Surgery 1992 163 6 602 605 10.1016/0002-9610(92)90567-B 2-s2.0-0026780312
19. Delva E., Camus Y., Nordlinger B., Hannoun L., Parc R., Deriaz H., Lienhart A., Huguet C., Vascular occlusions for liver resections. Operative management and tolerance to hepatic ischemia: 142 cases. Annals of Surgery 1989 209 2 211 218 10.1097/00000658-198902000-00012 2-s2.0-0024505106 (Pubitemid 19055323)
20. Henderson J. M., Liver transplantation and rejection: an overview. Hepato-Gastroenterology 1999 46 2 1482 1484 2-s2.0-0033063712 (Pubitemid 29313187)
21. Zweier J. L., Talukder M. A. H., The role of oxidants and free radicals in reperfusion injury. Cardiovascular Research 2006 70 2 181 190 10.1016/j.cardiores.2006.02.025 2-s2.0-33646055216
22. Lemasters J. J., V. Necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis. The American Journal of Physiology 1999 276 1 G1 G6 2-s2.0-0032608336 (Pubitemid 29063592)
23. Hirsch T., Marchetti P., Susin S. A., Dallaporta B., Zamzami N., Marzo I., Geuskens M., Kroemer G., The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 1997 15 13 1573 1581 10.1038/sj.onc.1201324 2-s2.0-0030698810 (Pubitemid 27464650)
24. Elmore S., Apoptosis: a review of programmed cell death. Toxicologic Pathology 2007 35 4 495 516 10.1080/01926230701320337 2-s2.0-34250308322 (Pubitemid 46911891)
25. Malhi H., Gores G. J., Lemasters J. J., Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 2006 43 2 supplement 1 S31 S44 10.1002/hep.21062 2-s2.0-33644524120